Industry
Pharmaceuticals
Topic
IPOs
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
IPOs in Pharmaceuticals
... Sage Therapeutics(NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central ...
... U.S. and EU under a standard review and we were pleased that Akcea received priority review in Canada. Akcea is well along in creating a ...
... Company continues to advance clinical trials of lead product candidate ALRN-6924 in PTCL and AML/MDS Two abstracts selected for oral presentations at American ...
... WESTLAKE VILLAGE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today reported the Company's financial results for the third quarter ...
... in early 2018 and has appointed a highly experienced executive from rival Swisse Wellness to run the company as it heads towards the ASX. Nature's ...
... Intel. This one will be a doozy to watch. FEMALE VIAGRA UPDATE: Valeant Pharmaceuticals will sell its female libido-pill business Sprout Pharmaceuticals back to its ...
... approval and promptly sold the company behind it for $1 billion to Valeant. Now, Whitehead has turned from entrepreneur to investor through her new venture ...
... Eleven Biotherapeutics, Inc. ("Eleven" or the "Company") (NASDAQ:EBIO), a late-stage clinical oncology company advancing ...
... NEWTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, ...
... CAMBRIDGE, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc., a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing ...
... run advocacy programs, raised $18.5 million in Series B funding. VC Draper Esprit led the round, and was joined by investors including Kindred, Frontline Ventures, ...
... BURLINGTON, Mass., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten public offering, ...
... Third Rock Ventures-backed Allena Pharmaceuticals is about to put investors’ renewed appetite for biotech IPOs to ...
... Cambridge, Massachusetts-based Spero Therapeutics, a biopharmaceutical company focused on developing treatments for bacterial infections, has ...
... filing to list on Nasdaq. A few years back it looked like Immatics might have undergone that evolution itself by now. Instead, the German biotech ...
... the deal. Celcuity plans to list on the Nasdaq as "CELC." [ts_bullet_primary] Krystal Biotech , a Pittsburgh, Penn.-based therapy company focused on dermatological diseases, priced ...
... list on the Nasdaq as "FAT." EXITS [ts_bullet_primary] Merck agreed to acquire Rigontec , a Germany-based company that focuses on RIG-I targeting RNA therapeutics. According ...
... Destiny Pharma has listed on London’s AIM exchange. The IPO gives Destiny £15.3 ...
... LLP is investigating potential claims against Forterra, Inc., Foundation Medicine, Inc., Teva Pharmaceutical Industries Limited, and Dr. Reddys Laboratories Limited as detailed below: Forterra, Inc. ...
... Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on ...
... substantially increased our financial strength and strategic flexibility through our collaboration with Celgene and our initial public offering," said Richard Murray, Ph.D., chief executive officer ...
... DEALS [ts_bullet_primary] Lionsgate (NYSE:LGF.A) is in talks to sell its stake in Epix , a New York City-based premium cable channel, to existing shareholders MGM ...
... BOTHELL, WA and ATLANTA, GA --(Marketwired - November 09, 2016) - Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for ...
... economies. This morning, Stock-Callers.com redirects its attention to the following stocks: Zoetis Inc. (NYSE: ZTS), Sophiris Bio Inc. (NASDAQ: SPHS), Rigel Pharmaceuticals Inc. (NASDAQ: RIGL), ...
... Oncology Ventures were joined by return backers like Column Group, Foresite Capital, Celgene and Novartis. The company previously raised $50 million. Read more. [ts_bullet_primary] LogRhythm ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤